Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
flu vaccine
Biotech
Moderna flu vaccine beats approved competitor in fresh ph. 3 win
The long and winding journey of Moderna’s mRNA flu vaccine toward regulators has come one step closer with a phase 3 win over an approved competitor.
James Waldron
Jun 30, 2025 8:05am
Moderna withdraws FDA filing for flu/COVID combination vaccine
May 21, 2025 9:35am
HHS unveils $500M universal vaccine development initiative
May 1, 2025 2:55pm
GSK's mRNA flu vaccine finally bests tricky B strains in phase 2
Sep 12, 2024 4:52am
Sanofi will drop dwarfism drug as part of rare disease clear-out
Jul 25, 2024 7:58am
CureVac, chasing Moderna mRNA flu shot, hits similar problems
Apr 4, 2024 9:30am
